tiprankstipranks
Trending News
More News >
Sqz Biotechnologies Company (SQZB)
:SQZB
US Market
Advertisement

SQZ Biotechnologies (SQZB) Price & Analysis

Compare
149 Followers

SQZB Stock Chart & Stats


SQZB FAQ

What was Sqz Biotechnologies Company’s price range in the past 12 months?
Sqz Biotechnologies Company lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
    What is Sqz Biotechnologies Company’s market cap?
    Sqz Biotechnologies Company’s market cap is $825.75K.
      When is Sqz Biotechnologies Company’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Sqz Biotechnologies Company’s earnings last quarter?
      Currently, no data Available
      Is Sqz Biotechnologies Company overvalued?
      According to Wall Street analysts Sqz Biotechnologies Company’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Sqz Biotechnologies Company pay dividends?
        Sqz Biotechnologies Company does not currently pay dividends.
        What is Sqz Biotechnologies Company’s EPS estimate?
        Sqz Biotechnologies Company’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Sqz Biotechnologies Company have?
        Sqz Biotechnologies Company has 29,491,125 shares outstanding.
          What happened to Sqz Biotechnologies Company’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Sqz Biotechnologies Company?
          Currently, no hedge funds are holding shares in SQZB

          Company Description

          Sqz Biotechnologies Company

          SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

          SQZ Biotechnologies (SQZB) Earnings & Revenues

          Similar Stocks
          Company
          Price & Change
          Follow
          Biodexa Pharmaceuticals
          TNF Pharmaceuticals
          Salarius Pharmaceuticals
          Scinai Immunotherapeutics
          Oragenics

          Ownership Overview

          5.49%94.51%
          Insiders
          5.49% Other Institutional Investors
          94.51% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis